APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
APOLLO-2: A randomized, placebo- and active-controlled phase III study evaluating oliceridine (TRV130), a G-protein-mediated ligand on the  -opioid receptor for the treatment of moderate to severe acute pain following abdominal surgery.